Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research

by NASDAQ Market News July 25, 2018

NASDAQ Market News
Click here to email author

Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47

Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018

Ads